×
S&P 500   3,872.37 (-0.71%)
DOW   31,326.71 (-0.35%)
QQQ   289.19 (-1.11%)
AAPL   140.35 (-0.92%)
MSFT   261.09 (-1.43%)
META   167.62 (-1.10%)
GOOGL   2,276.98 (-1.71%)
AMZN   109.60 (-3.20%)
TSLA   717.53 (-2.34%)
NVDA   163.46 (-3.10%)
NIO   22.33 (-2.70%)
BABA   117.90 (-0.70%)
AMD   81.86 (-4.99%)
MU   58.98 (+0.34%)
CGC   3.67 (-3.17%)
T   20.89 (+0.53%)
GE   66.73 (+0.03%)
F   12.09 (+0.42%)
DIS   98.80 (+2.27%)
AMC   13.61 (-3.68%)
PFE   51.28 (-1.16%)
PYPL   74.21 (-2.28%)
NFLX   184.26 (-2.58%)
S&P 500   3,872.37 (-0.71%)
DOW   31,326.71 (-0.35%)
QQQ   289.19 (-1.11%)
AAPL   140.35 (-0.92%)
MSFT   261.09 (-1.43%)
META   167.62 (-1.10%)
GOOGL   2,276.98 (-1.71%)
AMZN   109.60 (-3.20%)
TSLA   717.53 (-2.34%)
NVDA   163.46 (-3.10%)
NIO   22.33 (-2.70%)
BABA   117.90 (-0.70%)
AMD   81.86 (-4.99%)
MU   58.98 (+0.34%)
CGC   3.67 (-3.17%)
T   20.89 (+0.53%)
GE   66.73 (+0.03%)
F   12.09 (+0.42%)
DIS   98.80 (+2.27%)
AMC   13.61 (-3.68%)
PFE   51.28 (-1.16%)
PYPL   74.21 (-2.28%)
NFLX   184.26 (-2.58%)
S&P 500   3,872.37 (-0.71%)
DOW   31,326.71 (-0.35%)
QQQ   289.19 (-1.11%)
AAPL   140.35 (-0.92%)
MSFT   261.09 (-1.43%)
META   167.62 (-1.10%)
GOOGL   2,276.98 (-1.71%)
AMZN   109.60 (-3.20%)
TSLA   717.53 (-2.34%)
NVDA   163.46 (-3.10%)
NIO   22.33 (-2.70%)
BABA   117.90 (-0.70%)
AMD   81.86 (-4.99%)
MU   58.98 (+0.34%)
CGC   3.67 (-3.17%)
T   20.89 (+0.53%)
GE   66.73 (+0.03%)
F   12.09 (+0.42%)
DIS   98.80 (+2.27%)
AMC   13.61 (-3.68%)
PFE   51.28 (-1.16%)
PYPL   74.21 (-2.28%)
NFLX   184.26 (-2.58%)
S&P 500   3,872.37 (-0.71%)
DOW   31,326.71 (-0.35%)
QQQ   289.19 (-1.11%)
AAPL   140.35 (-0.92%)
MSFT   261.09 (-1.43%)
META   167.62 (-1.10%)
GOOGL   2,276.98 (-1.71%)
AMZN   109.60 (-3.20%)
TSLA   717.53 (-2.34%)
NVDA   163.46 (-3.10%)
NIO   22.33 (-2.70%)
BABA   117.90 (-0.70%)
AMD   81.86 (-4.99%)
MU   58.98 (+0.34%)
CGC   3.67 (-3.17%)
T   20.89 (+0.53%)
GE   66.73 (+0.03%)
F   12.09 (+0.42%)
DIS   98.80 (+2.27%)
AMC   13.61 (-3.68%)
PFE   51.28 (-1.16%)
PYPL   74.21 (-2.28%)
NFLX   184.26 (-2.58%)
NYSE:AVTR

Avantor Stock Forecast, Price & News

$31.77
-0.22 (-0.69%)
(As of 06/28/2022 11:22 AM ET)
Add
Compare
Today's Range
$31.67
$32.16
50-Day Range
$29.35
$33.38
52-Week Range
$28.64
$44.37
Volume
25,041 shs
Average Volume
4.21 million shs
Market Capitalization
$19.39 billion
P/E Ratio
35.70
Dividend Yield
N/A
Price Target
$43.60
30 days | 90 days | 365 days | Advanced Chart

Receive AVTR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Avantor and its competitors with MarketBeat's FREE daily newsletter.

AVTR Stock Forecast (MarketRank)

Overall MarketRank

2.98 out of 5 stars

Medical Sector

20th out of 1,436 stocks

Analytical Instruments Industry

2nd out of 33 stocks

Analyst Opinion: 4.5Community Rank: 4.8Dividend Strength: 0.0Insider Behavior: 2.5Valuation: 3.1 5 -4 -3 -2 -1 -
Avantor logo

About Avantor (NYSE:AVTR)

Avantor, Inc. provides products and services to customers in biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips. It also provides equipment and instrumentation products, including filtration systems, virus inactivation systems, incubators, analytical instruments, evaporators, ultra-low-temperature freezers, biological safety cabinets, and critical environment supplies. In addition, the company offers services and specialty procurements comprising onsite lab and production, clinical, equipment, procurement and sourcing, and biopharmaceutical material scale-up and development services. Avantor, Inc. was founded in 1904 and is headquartered in Radnor, Pennsylvania.

AVTR Stock News Headlines

Avantor, Inc. (NYSE:AVTR) Has A ROE Of 14%
See More Headlines

Industry, Sector and Symbol

Industry
Analytical instruments
Sub-Industry
N/A
Sector
Medical
Fax
N/A
Employees
13,500
Year Founded
N/A

Company Calendar

Last Earnings
4/28/2022
Today
6/28/2022
Next Earnings (Estimated)
8/04/2022
Fiscal Year End
12/31/2022

Price Target and Rating

Average Stock Price Forecast
$43.60
High Stock Price Forecast
$51.00
Low Stock Price Forecast
$33.00
Forecasted Upside/Downside
+37.2%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.9375
Research Coverage
16 Analysts

Profitability

Net Income
$572.60 million
Pretax Margin
10.38%

Debt

Sales & Book Value

Annual Sales
$7.39 billion
Cash Flow
$2.11 per share
Book Value
$5.24 per share

Miscellaneous

Free Float
600,574,000
Market Cap
$19.39 billion
Optionable
Not Optionable
Beta
1.53














Avantor Frequently Asked Questions

Should I buy or sell Avantor stock right now?

16 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Avantor in the last year. There are currently 1 hold rating and 15 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "moderate buy" Avantor stock.
View analyst ratings for Avantor
or view top-rated stocks.

What is Avantor's stock price forecast for 2022?

16 brokerages have issued 1 year price targets for Avantor's stock. Their AVTR stock forecasts range from $33.00 to $51.00. On average, they expect Avantor's share price to reach $43.60 in the next twelve months. This suggests a possible upside of 37.2% from the stock's current price.
View analysts' price targets for Avantor
or view top-rated stocks among Wall Street analysts.

How has Avantor's stock price performed in 2022?

Avantor's stock was trading at $42.14 at the beginning of the year. Since then, AVTR stock has decreased by 24.6% and is now trading at $31.77.
View the best growth stocks for 2022 here
.

Are investors shorting Avantor?

Avantor saw a decline in short interest in the month of May. As of May 31st, there was short interest totaling 6,160,000 shares, a decline of 61.1% from the May 15th total of 15,840,000 shares. Based on an average daily trading volume, of 5,420,000 shares, the days-to-cover ratio is currently 1.1 days. Currently, 1.1% of the company's stock are short sold.
View Avantor's Short Interest
.

When is Avantor's next earnings date?

Avantor is scheduled to release its next quarterly earnings announcement on Thursday, August 4th 2022.
View our earnings forecast for Avantor
.

How were Avantor's earnings last quarter?

Avantor, Inc. (NYSE:AVTR) announced its quarterly earnings data on Thursday, April, 28th. The company reported $0.38 earnings per share for the quarter, topping the consensus estimate of $0.35 by $0.03. The company earned $1.95 billion during the quarter, compared to analysts' expectations of $1.93 billion. Avantor had a trailing twelve-month return on equity of 32.17% and a net margin of 7.72%. The firm's revenue for the quarter was up 9.2% on a year-over-year basis. During the same quarter last year, the firm earned $0.35 EPS.
View Avantor's earnings history
.

What guidance has Avantor issued on next quarter's earnings?

Avantor issued an update on its FY 2022 earnings guidance on Monday, May, 9th. The company provided earnings per share guidance of $1.48-$1.54 for the period, compared to the consensus EPS estimate of $1.50. The company issued revenue guidance of -.

Who are Avantor's key executives?

Avantor's management team includes the following people:

What other stocks do shareholders of Avantor own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Avantor investors own include (HON), Johnson & Johnson (JNJ), NVIDIA (NVDA), Procter & Gamble (PG), Raytheon Technologies (RTX), Alibaba Group (BABA), CVS Health (CVS), Home Depot (HD), Pfizer (PFE) and QUALCOMM (QCOM).

When did Avantor IPO?

(AVTR) raised $3 billion in an initial public offering (IPO) on Friday, May 17th 2019. The company issued 154,000,000 shares at $18.00-$21.00 per share. Goldman Sachs, J.P. Morgan, BofA Merrill Lynch, Barclays and Jefferies served as the underwriters for the IPO and Credit Suisse, Deutsche Bank Securities, Evercore ISI, Guggenheim Securities, Morgan Stanley, UBS Investment Bank, Citigroup, Cowen, Piper Jaffray, RBC Capital Markets, Baird, William Blair, Janney Montgomery Scott, KeyBanc Capital Markets, PJT Partners, Raymond James, Stephens, Stifel, SunTrust Robinson Humphrey, Wells Fargo Securities and Drexel Hamilton were co-managers.

What is Avantor's stock symbol?

Avantor trades on the New York Stock Exchange (NYSE) under the ticker symbol "AVTR."

Who are Avantor's major shareholders?

Avantor's stock is owned by many different retail and institutional investors. Top institutional shareholders include Vanguard Group Inc. (8.32%), Canada Pension Plan Investment Board (4.02%), Boston Partners (3.24%), Third Point LLC (1.37%), Parnassus Investments LLC (1.17%) and Robeco Schweiz AG (0.92%). Company insiders that own Avantor stock include Christi Shaw, Christophe Couturier, David D Petratis, Devashish Ohri, Frederic Vanderhaegen, Gerard Brophy, James Bramwell, Jo Natauri, Justin Miller, Michael Stubblefield, Michael Wondrasch, New Mountain Investments Iii,, Rajiv Gupta and Steven W Eck.
View institutional ownership trends for Avantor
.

Which institutional investors are selling Avantor stock?

AVTR stock was sold by a variety of institutional investors in the last quarter, including Viking Global Investors LP, Third Point LLC, Aviva PLC, Jennison Associates LLC, Victory Capital Management Inc., First Trust Advisors LP, Los Angeles Capital Management LLC, and Nordea Investment Management AB. Company insiders that have sold Avantor company stock in the last two years include Christi Shaw, Christophe Couturier, David D Petratis, Devashish Ohri, Frederic Vanderhaegen, Gerard Brophy, James Bramwell, Jo Natauri, Justin Miller, Michael Stubblefield, Michael Wondrasch, New Mountain Investments Iii,, Rajiv Gupta, and Steven W Eck.
View insider buying and selling activity for Avantor
or view top insider-selling stocks.

Which institutional investors are buying Avantor stock?

AVTR stock was bought by a variety of institutional investors in the last quarter, including Steadfast Capital Management LP, Brown Advisory Inc., Parnassus Investments LLC, Robeco Schweiz AG, Robeco Institutional Asset Management B.V., Wilson Asset Management International PTY Ltd., Eagle Asset Management Inc., and Boston Partners.
View insider buying and selling activity for Avantor
or or view top insider-buying stocks.

How do I buy shares of Avantor?

Shares of AVTR can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Avantor's stock price today?

One share of AVTR stock can currently be purchased for approximately $31.77.

How much money does Avantor make?

Avantor (NYSE:AVTR) has a market capitalization of $19.39 billion and generates $7.39 billion in revenue each year. The company earns $572.60 million in net income (profit) each year or $0.889990 on an earnings per share basis.

How many employees does Avantor have?

Avantor employs 13,500 workers across the globe.

How can I contact Avantor?

Avantor's mailing address is BUILDING ONE SUITE 200 100 MATSONFORD ROAD, RADNOR PA, 19087. The official website for Avantor is www.avantorsciences.com. The company can be reached via phone at (610) 386-1700 or via email at [email protected].

This page (NYSE:AVTR) was last updated on 6/28/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer.